Literature DB >> 21392883

Treatment of recurrent high grade gliomas with hypofractionated stereotactic image-guided helical tomotherapy.

Brian Kim1, Emilie Soisson, Christopher Duma, Peter Chen, Russell Hafer, Craig Cox, Jim Cubellis, Annamarie Minion, Marianne Plunkett, Ralph Mackintosh.   

Abstract

OBJECTIVE: Salvage treatment of high grade gliomas that progress after standard therapy of resection and adjuvant chemoradiation therapy includes repeat surgical resection, second line chemotherapy, re-irradiation, or often a combination of the above. We present a series on patients treated with hypofractionated stereotactic image-guided helical tomotherapy and discuss the efficacy of this new technology in the treatment of high grade gliomas.
MATERIALS AND METHODS: Between June 2005 and August of 2008, eight patients with recurrent high grade gliomas were treated with salvage radiation therapy using hypofractionated stereotactic image-guided helical tomotherapy after image documentation of disease progression. Median age was 48.5 years with 4 females and 4 males. Median KPS at time of treatment was 65. All patients had either Grade III or IV gliomas at time of treatment with previous history of involved field fractionated radiotherapy. Median total dose given was 2500cGy in 500cGy fractions.
RESULTS: The median planning target volume was 69.5cm(3). Five of the eight patients were alive at the time of last follow-up with a median survival of 7.6 months. Radiographic documented control was seen in six of the eight patients with median local control of 4.6 months. Acute Radiation Therapy Oncology Group (RTOG) toxicity scores measured zero in all patients with only one patient requiring a reoperation following treatment.
CONCLUSIONS: Hypofractionated stereotactic image-guided helical tomotherapy provides an alternative to other stereotactic radiation therapy and radiosurgery options for treatment of recurrent high grade gliomas.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21392883     DOI: 10.1016/j.clineuro.2011.02.001

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  9 in total

Review 1.  Recurrent malignant gliomas.

Authors:  John P Kirkpatrick; John H Sampson
Journal:  Semin Radiat Oncol       Date:  2014-10       Impact factor: 5.934

2.  Precision radiotherapy for brain tumors: A 10-year bibliometric analysis.

Authors:  Ying Yan; Zhanwen Guo; Haibo Zhang; Ning Wang; Ying Xu
Journal:  Neural Regen Res       Date:  2012-08-05       Impact factor: 5.135

3.  Re-irradiation alternatives for recurrent high-grade glioma.

Authors:  Yuanli Dong; Chengrui Fu; Hui Guan; Tianyi Zhang; Zicheng Zhang; Tao Zhou; Baosheng Li
Journal:  Oncol Lett       Date:  2016-08-01       Impact factor: 2.967

4.  Intracranial Stereotactic Radiation Therapy With a Jawless Ring Gantry Linear Accelerator Equipped With New Dual Layer Multileaf Collimator.

Authors:  Nels C Knutson; William R Kennedy; Francisco J Reynoso; Jiayuan Peng; Lauren E Henke; Eric Laugeman; Michael Watts; Jessica Hillard; Ana Heermann; Geoffrey D Hugo; Sasa Mutic; Bin Cai
Journal:  Adv Radiat Oncol       Date:  2020-01-28

5.  Re-irradiation of recurrent glioblastoma using helical TomoTherapy with simultaneous integrated boost: preliminary considerations of treatment efficacy.

Authors:  Donatella Arpa; Elisabetta Parisi; Giulia Ghigi; Alessandro Savini; Sarah Pia Colangione; Luca Tontini; Martina Pieri; Flavia Foca; Rolando Polico; Anna Tesei; Anna Sarnelli; Antonino Romeo
Journal:  Sci Rep       Date:  2020-11-09       Impact factor: 4.379

6.  Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma.

Authors:  Donatella Arpa; Elisabetta Parisi; Giulia Ghigi; Annalisa Cortesi; Pasquale Longobardi; Patrizia Cenni; Martina Pieri; Luca Tontini; Elisa Neri; Simona Micheletti; Francesca Ghetti; Manuela Monti; Flavia Foca; Anna Tesei; Chiara Arienti; Anna Sarnelli; Giovanni Martinelli; Antonio Romeo
Journal:  Front Oncol       Date:  2021-03-30       Impact factor: 6.244

Review 7.  Relapsing High-Grade Glioma from Peritumoral Zone: Critical Review of Radiotherapy Treatment Options.

Authors:  Maria Chiara Lo Greco; Roberto Milazzotto; Rocco Luca Emanuele Liardo; Grazia Acquaviva; Madalina La Rocca; Roberto Altieri; Francesco Certo; Giuseppe Maria Barbagallo; Antonio Basile; Pietro Valerio Foti; Stefano Palmucci; Stefano Pergolizzi; Antonio Pontoriero; Corrado Spatola
Journal:  Brain Sci       Date:  2022-03-22

8.  Safety of Inhomogeneous Dose Distribution IMRT for High-Grade Glioma Reirradiation: A Prospective Phase I/II Trial (GLIORAD TRIAL).

Authors:  Patrizia Ciammella; Salvatore Cozzi; Andrea Botti; Lucia Giaccherini; Roberto Sghedoni; Matteo Orlandi; Manuela Napoli; Rosario Pascarella; Anna Pisanello; Marco Russo; Francesco Cavallieri; Maria Paola Ruggieri; Silvio Cavuto; Luisa Savoldi; Cinzia Iotti; Mauro Iori
Journal:  Cancers (Basel)       Date:  2022-09-22       Impact factor: 6.575

9.  Conventionally fractionated stereotactic radiotherapy (CFRT) in combination with dose-dense temozolomide (TMZ) in relapsed malignant glioma: A case report.

Authors:  Shuai Qie; Lanhui Yuan; Hong-Yun Shi; Xi Zhang; Yanhong Li
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.